Multimodality Cardiovascular Imaging in the Midst of the COVID-19 Pandemic: Ramping Up Safely to a New Normal

William A Zoghbi, Marcelo F DiCarli, Ron Blankstein, Andrew D Choi, Vasken Dilsizian, Frank A Flachskampf, Jeffrey B Geske, Paul A Grayburn, Farouc A Jaffer, Raymond Y Kwong, Jonathan A Leipsic, Thomas H Marwick, Eike Nagel, Koen Nieman, Subha V Raman, Michael Salerno, Partho P Sengupta, Leslee J Shaw, Y S Chandrashekhar, ACC Imaging Council, William A Zoghbi, Marcelo F DiCarli, Ron Blankstein, Andrew D Choi, Vasken Dilsizian, Frank A Flachskampf, Jeffrey B Geske, Paul A Grayburn, Farouc A Jaffer, Raymond Y Kwong, Jonathan A Leipsic, Thomas H Marwick, Eike Nagel, Koen Nieman, Subha V Raman, Michael Salerno, Partho P Sengupta, Leslee J Shaw, Y S Chandrashekhar, ACC Imaging Council

No abstract available

Keywords: COVID-19; cardiac computer tomography; cardiac magnetic resonance; cardiovascular imaging; echocardiography; nuclear cardiology.

Figures

Central Illustration
Central Illustration
Role of Cardiovascular Imaging in the COVID-19 Era Dynamic changes in the utilization and role of cardiovascular imaging during the different phases of the COVID-19 pandemic. COVID-19 = coronavirus disease 2019; CV = cardiovascular.

References

    1. Centers for Disease Control and Prevention Coronavirus (COVID-19) Available at:
    1. Kirkpatrick J.N., Mitchell C., Taub C., Kort S., Hung J., Swaminathan M. ASE statement on protection of patients and echocardiography service providers during the 2019 novel coronavirus outbreak. J Am Coll Cardiol. 2020;75:3078–3084.
    1. Skali H., Murthy V.L., Al-Mallah M.H. Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI. J Nucl Med. 2020;61:784–791.
    1. Choi A.D., Abbara S., Branch K.R. Society of Cardiovascular Computed Tomography guidance for use of cardiac computed tomography amid the COVID-19 pandemic. J Cardiovasc Comput Tomogr. 2020;14:101–104.
    1. Society for Cardiovascular Magnetic Resonance SCMR’S COVID-19 preparedness toolkit. Available at:
    1. Skulstad H., Cosyns B., Popescu B.A. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and health care personnel. Eur Heart J Cardiovasc Imaging. 2020;21:592–598.
    1. European Society of Cardiology ESC guidance for the diagnosis and management of CV disease during the COVID-19 Pandemic. Available at:
    1. Wood D.A., Mahmud E., Thourani V.H. Safe reintroduction of cardiovascular services during the COVID-19 pandemic: guidance from North American Society Leadership. J Am Coll Cardiol. 2020 May 4 [E-pub ahead of print]
    1. Hung J., Abraham T.P., Cohen M.S. ASE statement on the reintroduction of echocardiography services during the COVID-19 pandemic. J Am Soc Echocardiogr. 2020 May 20 [E-pub ahead of print]
    1. Skali H., Murthy V., Paez D. Guidance and best practices for reestablishment of non-emergent care in nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: an information statement from ASNC, IAEA, and SNMMI. J Nucl Cardiol. 2020 May 14 [E-pub ahead of print]
    1. Han Y., Chen T., Bryant J. Society for Cardiovascular Magnetic Resonance (SCMR) guidance for the practice of cardiovascular magnetic resonance during the COVID-19 pandemic. J Cardiovasc Magn Reson. 2020;22:26.
    1. Kucirka L.M., Lauer S.A., Laeyendecker O., Boon D., Lessler J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction–based SARS-CoV-2 tests by time since exposure. Ann Intern Med. 2020 May 13 [E-pub ahead of print]
    1. Wang W., Xu Y., Gao R. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323:1843–1844.
    1. U.S. Food & Drug Administration FAQs on testing for SARS-CoV-2. Available at:
    1. Wolk M.J., Bailey S.R., Doherty J.U. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;63:380–406.
    1. AJ T., Cerqueira M., JM H., Mark D., Min J., O’Gara P. ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2010;56:1864–1894.
    1. American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Endorsed by the American College of Chest Physicians. J Am Coll Cardiol. 2011;57:1126–1166.
    1. Doherty J.U., Kort S., Mehran R., Schoenhagen P., Soman P. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 appropriate use criteria for multimodality imaging in valvular heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2017;70:1647–1672.
    1. Doherty J.U., Kort S., Mehran R. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2019;73:488–516.
    1. Habib G., Lancellotti P., Antunes M.J. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM) Eur Heart J. 2015;36:3075–3128.
    1. Patel M.R., White R.D., Abbara S. 2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR appropriate utilization of cardiovascular imaging in heart failure: a joint report of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Foundation Appropriate Use Criteria Task Force. J Am Coll Cardiol. 2013;61:2207–2231.
    1. Zhou F., Yu T., Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062.
    1. Li Y., Li H., Zhu S. Prognostic value of right ventricular longitudinal strain in patients with COVID-19. J Am Coll Cardiol Img. 2020 Apr 28 [E-pub ahead of print]
    1. Johri A.M., Galen B., Kirkpatrick J.N., Lanspa M., Mulvagh S., Thamman R. ASE statement on point-of-care ultrasound (POCUS) during the 2019 novel coronavirus pandemic. J Am Soc Echocardiogr. 2020;33:670–673.
    1. Porter T.R., Mulvagh S.L., Abdelmoneim S.S. Clinical applications of ultrasonic enhancing agents in echocardiography: 2018 American Society of Echocardiography guidelines update. J Am Soc Echocardiogr. 2018;31:241–274.
    1. Gewirtz H., Dilsizian V. Myocardial viability: survival mechanisms and molecular imaging targets in acute and chronic ischemia. Circ Res. 2017;120:1197–1212.
    1. Dilsizian V., Bacharach S.L., Beanlands R.S. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016;23:1187–1226.
    1. Mathew R.C., Bourque J.M., Salerno M., Kramer C.M. Cardiovascular imaging techniques to assess microvascular dysfunction. J Am Coll Cardiol Img. 2019 Oct 11 [E-pub ahead of print]
    1. Chareonthaitawee P., Beanlands R.S., Chen W. Joint SNMMI-ASNC Expert Consensus document on the role of (18)F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med. 2017;58:1341–1353.
    1. Gillmore J.D., Maurer M.S., Falk R.H. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133:2404–2412.
    1. Kim J., Feller E.D., Chen W., Liang Y., Dilsizian V. FDG PET/CT for early detection and localization of left ventricular assist device infection: impact on patient management and outcome. J Am Coll Cardiol Img. 2019;12:722–729.
    1. Shi S., Qin M., Shen B. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Mar 25 [E-pub ahead of print]
    1. Linde J.J., Kelbæk H., Hansen T.F. Coronary CT angiography in patients with non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol. 2020;75:453–463.
    1. Smulders M.W., Kietselaer B.L., Wildberger J.E. Initial imaging-guided strategy versus routine care in patients with non–ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2019;74:2466–2477.
    1. Pontone G., Baggiano A., Conte E. “Quadruple rule out” with cardiac computed tomography in COVID-19 patient with equivocal acute coronary syndrome presentation. J Am Coll Cardiol Img. 2020 Apr 21 [E-pub ahead of print]
    1. Feuchtner G., Plank F., Mueller S. Cardiac CTA for evaluation of prosthetic valve dysfunction. J Am Coll Cardiol Img. 2017;10:91–93.
    1. Kim I., Chang S., Hong G. Comparison of cardiac computed tomography with transesophageal echocardiography for identifying vegetation and intracardiac complications in patients with infective endocarditis in the era of 3-dimensional images. Circ Cardiovasc Imaging. 2018;11
    1. Hendel R.C., Friedrich M.G., Schulz-Menger J. CMR first-pass perfusion for suspected inducible myocardial ischemia. J Am Coll Cardiol Img. 2016;9:1338–1348.
    1. D’Angelo T., Grigoratos C., Mazziotti S. High-throughput gadobutrol-enhanced CMR: a time and dose optimization study. J Cardiovasc Magn Reson. 2017;19:83.
    1. Foley J.R., Richmond C., Fent G.J. Rapid Cardiovascular Magnetic Resonance for Ischemic Heart Disease Investigation (RAPID-IHD) J Am Coll Cardiol Img. 2020 Apr 15 [E-pub ahead of print]
    1. Chen J., Zhang H., Zhu D., Wang Y., Byanju S., Liao M. Cardiac MRI for detecting left atrial/left atrial appendage thrombus in patients with atrial fibrillation : Meta-analysis and systematic review. Herz. 2019;44:390–397.
    1. Kitkungvan D., Nabi F., Ghosn M.G. Detection of LA and LAA thrombus by CMR in patients referred for pulmonary vein isolation. J Am Coll Cardiol Img. 2016;9:809–818.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe